CiteFacts · FDA Drug Shortages · FDA source
Conivaptan Hydrochloride Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc. | Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10) | Unavailable | 08/18/2026 |
Source facts
Grouped generic ingredient: Conivaptan Hydrochloride Injection · 1 package records · Latest FDA row update: 08/18/2026
Therapeutic categories: Cardiovascular
Dosage forms: Injection
Routes: Not stated
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.